Access the nVentic Big Pharma inventory trends benchmark report 2025
Inside This Report:
- Gain insight on the 3-year trend (2022-2024) driving aggressive vs. controlled inventory strategies in Big Pharma.
- Benchmark your company’s performance against a newly segmented list of top-tier and high-DIO peers.
- Understand why industry capital tie-up is at “near-unprecedented” levels (and who is most exposed).
Share this insight:
All of our insights are available free and without registration. You can find more articles on our main Insights page.
More Insights
Content Subscription
Would you like to receive more content like this, direct to your inbox? We publish white papers on a range of supply chain topics approximately once every one to two months. Subscribe below and we will notify you of new content. Unsubscribe at any time.